Entrada Therapeutics Cash Flow Statement 2019-2024 | TRDA

Fifteen years of historical annual cash flow statements for Entrada Therapeutics (TRDA).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-6.69$-94.62$-51.16$-26.52$-5.10
$-2.94$2.05$1.12$0.33$0.10
$25.10$17.55$2.60$0.35$-5.98
$22.16$19.59$3.72$0.67$-5.88
$0$0$0$0$0
$0$0$0$0$0
$-2.81$5.29$-0.72$0.63$0.37
$119$-25.81$-6.67$-0.93$-0.47
$124$-18.76$-3.42$0.28$0.17
$140$-93.79$-50.86$-25.57$-10.80
$-5.61$-2.89$-4.58$-2.32$-0.63
$0$0$0$0$0
$0$0$0$0$0
$-132.78$-145.76$0$0$0
$0$0$0$0$0
$-132.78$-145.76$0$0$0
$0$0$0$0$0
$-138.40$-148.65$-4.58$-2.32$-0.63
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$21.04$0.48$192$0.25$0.04
$21.04$0.48$307$50.09$0.04
$0$0$0$0$0
$0$0$0$0$0
$21.04$0.48$307$50.09$0.04
$22.45$-241.96$252$22.20$-11.39
$13.11$9.90$2.53$0.33$0.29
$0$0$0$0$0